Tonix Pharmaceuticals Holding Corp. Company Profile (NASDAQ:TNXP)

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TNXP
  • CUSIP:
Key Metrics:
  • Previous Close: $0.55
  • 50 Day Moving Average: $0.551
  • 200 Day Moving Average: $0.869
  • 52-Week Range: $0.35 - $3.77
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.74
  • P/E Growth: 0.000
  • Market Cap: $21.47M
  • Outstanding Shares: 39,181,000
  • Beta: 2.92
Profitability:
  • Return on Equity: -140.86%
  • Return on Assets: -123.32%
Debt:
  • Current Ratio: 11.15%
  • Quick Ratio: 11.15%
Additional Links:
Companies Related to Tonix Pharmaceuticals Holding Corp.:

Analyst Ratings

Consensus Ratings for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (?)
Ratings Breakdown: 3 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $8.67 (1,481.51% upside)

Analysts' Ratings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Show:
DateFirmActionRatingPrice TargetDetails
12/20/2016Oppenheimer Holdings, Inc.Reiterated RatingHoldView Rating Details
9/7/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
9/7/2016Cantor FitzgeraldDowngradeBuy -> HoldView Rating Details
6/30/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/2/2017        
11/10/2016Q3 2016($0.34)($0.29)ViewN/AView Earnings Details
5/9/2016Q1($0.63)($0.74)ViewN/AView Earnings Details
3/4/2016Q4($0.66)($0.71)ViewN/AView Earnings Details
8/10/2015Q215($0.65)($0.73)ViewN/AView Earnings Details
5/11/2015Q115($0.54)($0.71)ViewN/AView Earnings Details
3/3/2015Q414($0.81)($0.83)ViewN/AView Earnings Details
11/10/2014Q314($0.69)($0.71)ViewN/AView Earnings Details
8/8/2014Q214($0.53)($0.61)ViewN/AView Earnings Details
5/13/2014Q114($0.35)($0.59)ViewN/AView Earnings Details
3/31/2014($0.46)($0.74)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Current Year EPS Consensus Estimate: $-1.430 EPS
Next Year EPS Consensus Estimate: $-0.740 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.58)($0.58)($0.58)
Q2 20163($0.63)($0.49)($0.56)
Q3 20163($0.39)($0.30)($0.34)
Q4 20163($0.22)($0.13)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Insider Ownership Percentage: 10.20%
Institutional Ownership Percentage: 10.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/23/2016Ernest MarioDirectorBuy120,000$0.41$49,200.00View SEC Filing  
9/13/2016Ernest MarioDirectorBuy100,000$0.79$79,000.00View SEC Filing  
6/22/2016Seth LedermanCEOBuy20,000$2.08$41,600.00View SEC Filing  
6/21/2016Bradley SaengerCFOBuy2,000$2.00$4,000.00View SEC Filing  
6/21/2016Bruce DaughertyInsiderBuy100,000$2.00$200,000.00View SEC Filing  
6/21/2016John B RhodesDirectorBuy25,000$2.00$50,000.00View SEC Filing  
6/3/2016Gregory M SullivanInsiderBuy20,000$2.50$50,000.00View SEC Filing  
5/12/2016Ernest MarioDirectorBuy31,042$2.30$71,396.60View SEC Filing  
5/11/2016Ernest MarioDirectorBuy8,210$2.24$18,390.40View SEC Filing  
3/23/2016Seth LedermanCEOBuy8,000$2.44$19,520.00View SEC Filing  
3/16/2016Ernest MarioDirectorBuy75,000$2.29$171,750.00View SEC Filing  
9/30/2015Gregory M SullivanInsiderBuy5,000$5.18$25,900.00View SEC Filing  
9/28/2015Gregory M SullivanInsiderBuy4,694$5.95$27,929.30View SEC Filing  
9/25/2015Seth LedermanCEOBuy6,000$6.50$39,000.00View SEC Filing  
8/26/2015Ernest MarioDirectorBuy10,000$6.05$60,500.00View SEC Filing  
8/25/2015Ernest MarioDirectorBuy1,468$6.40$9,395.20View SEC Filing  
8/24/2015Ernest MarioDirectorBuy2,532$6.20$15,698.40View SEC Filing  
8/20/2015Ernest MarioDirectorBuy6,000$6.64$39,840.00View SEC Filing  
8/17/2015Ernest MarioDirectorBuy15,000$6.93$103,950.00View SEC Filing  
7/17/2015John B RhodesDirectorBuy6,000$7.50$45,000.00View SEC Filing  
7/17/2015Leland GershellCFOBuy1,000$7.50$7,500.00View SEC Filing  
6/11/2015Gregory M SullivanInsiderBuy4,500$8.38$37,710.00View SEC Filing  
3/17/2015Seth LedermanCEOBuy2,000$7.02$14,040.00View SEC Filing  
3/13/2015Seth LedermanCEOBuy2,000$7.24$14,480.00View SEC Filing  
3/11/2015Seth LedermanCEOBuy2,000$6.95$13,900.00View SEC Filing  
3/10/2015Charles E Iv MatherDirectorBuy1,000$6.80$6,800.00View SEC Filing  
3/9/2015Seth LedermanCEOBuy2,000$6.48$12,960.00View SEC Filing  
3/6/2015Ernest MarioDirectorBuy4,000$6.57$26,280.00View SEC Filing  
3/5/2015Seth LedermanCEOBuy2,000$6.27$12,540.00View SEC Filing  
2/9/2015Ernest MarioDirectorBuy30,000$5.85$175,500.00View SEC Filing  
2/9/2015Leland GershellCFOBuy5,000$5.85$29,250.00View SEC Filing  
9/27/2013Charles E Iv MatherDirectorBuy1,000$3.65$3,650.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
DateHeadline
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Daily Sentiment Score At 0.073 - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - February 17 at 7:01 PM
seekingalpha.com logoTonix Pharmaceuticals (TNXP) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:TNXP)
seekingalpha.com - February 16 at 8:08 PM
seekingalpha.com logoTonix Pharmaceuticals (TNXP) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:TNXP)
seekingalpha.com - February 16 at 8:08 PM
seekingalpha.com logoTonix Pharmaceuticals (TNXP) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:TNXP)
seekingalpha.com - February 16 at 8:08 PM
News IconAnalysts Weigh in on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): Consensus Notes - Rockville Register (NASDAQ:TNXP)
rockvilleregister.com - February 14 at 6:34 AM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Quarterly EPS At $-0.16 - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - February 14 at 6:34 AM
streetinsider.com logoTonix Pharma (TNXP) to Present at 2017 BIO CEO & Investor Conference (NASDAQ:TNXP)
www.streetinsider.com - February 11 at 5:39 AM
streetinsider.com logoTonix Pharma (TNXP) to Present at 2017 BIO CEO & Investor Conference - StreetInsider.com (NASDAQ:TNXP)
www.streetinsider.com - February 10 at 6:08 AM
finance.yahoo.com logoTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor Conference (NASDAQ:TNXP)
finance.yahoo.com - February 10 at 6:08 AM
4-traders.com logoTonix Pharmaceuticals : How These Drug Makers Stocks are Faring? -- Provectus Biopharma, TherapeuticsMD, Novartis, and Tonix Pharma (NASDAQ:TNXP)
www.4-traders.com - February 4 at 5:17 AM
investornewswire.com logoStrong Sell Recommendations Of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) At 0 - Investor Newswire (NASDAQ:TNXP)
www.investornewswire.com - January 29 at 10:58 PM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Daily Sentiment Score At 0.26 - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - January 27 at 6:18 AM
News IconEarnings in Full Force, Analysts Take Aim at Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Wall Street Beacon (NASDAQ:TNXP)
wsbeacon.com - January 27 at 6:18 AM
us.rd.yahoo.com logoTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at NobleCon13 (NASDAQ:TNXP)
us.rd.yahoo.com - January 25 at 7:31 AM
News IconQuarterly EPS Of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Set At $-0.16 - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - January 24 at 4:54 AM
investornewswire.com logoTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:TNXP)
www.investornewswire.com - January 22 at 7:59 PM
News IconTonix Pharmaceuticals Holding Corp TNXP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:TNXP)
www.bioportfolio.com - January 17 at 10:38 AM
4-traders.com logoTonix Pharmaceuticals Holding Corp. Average Rating At 4.57 (NASDAQ:TNXP)
www.4-traders.com - January 14 at 6:36 AM
News IconTonix Pharmaceuticals Holding Corp TNXP Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:TNXP)
www.bioportfolio.com - January 13 at 1:48 AM
News IconTonix Pharma Release: Company Presented Details Of Newly Expanded Product Development Pipeline At Conference (NASDAQ:TNXP)
www.biospace.com - January 12 at 5:32 AM
streetinsider.com logoForm 8-K Tonix Pharmaceuticals For: Jan 10 (NASDAQ:TNXP)
www.streetinsider.com - January 11 at 6:44 AM
us.rd.yahoo.com logoTonix Pharmaceuticals Presented Details of Newly Expanded Product Development Pipeline at 9th Annual Biotech Showcase Conference (NASDAQ:TNXP)
us.rd.yahoo.com - January 11 at 6:44 AM
News IconBearish Target Of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) At $2 - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - January 8 at 5:31 AM
News IconChelsea's Mikel joins China gold rush with move to Tianjin (NASDAQ:TNXP)
baddgoddess.com - January 6 at 6:12 AM
finance.yahoo.com logoTNXP: TNX-102 SL Given Breakthrough Therapy Designation for PTSD… (NASDAQ:TNXP)
finance.yahoo.com - January 5 at 7:08 AM
reuters.com logoBRIEF-Tonix Pharmaceuticals Holding says intends to commence 12-week phase 3 honor study, evaluating tnx-102 sl, 5.6 mg, in military-related ptsd (NASDAQ:TNXP)
www.reuters.com - January 4 at 7:01 AM
marketexclusive.com logoTONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure (NASDAQ:TNXP)
marketexclusive.com - January 4 at 7:01 AM
biz.yahoo.com logoTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:TNXP)
biz.yahoo.com - January 4 at 7:01 AM
News IconTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at 9th ... - EconoTimes (NASDAQ:TNXP)
www.econotimes.com - January 3 at 9:16 AM
finance.yahoo.com logoTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at 9th Annual Biotech Showcase Conference (NASDAQ:TNXP)
finance.yahoo.com - January 3 at 9:16 AM
live-pr.com logoTonix Pharmaceuticals Holding Corp. (TNXP) - Medical Equipment - Deals and Alliances Profile - New Study Released (NASDAQ:TNXP)
www.live-pr.com - December 31 at 2:06 AM
News IconTonix Pharmaceuticals Holding Corp. (TNXP) Broker Price Targets For The Coming Week (NASDAQ:TNXP)
vouxmagazine.com - December 31 at 2:06 AM
News IconTonix Pharmaceuticals Holding Corp. (TNXP) Sees Large Increase in Short Interest (NASDAQ:TNXP)
thecelebritytruth.com - December 31 at 2:06 AM
4-traders.com logoTonix Pharmaceuticals : Drug Makers Stocks on Investors' Radar -- Provectus Biopharma, Novartis, TherapeuticsMD, and Tonix Pharma (NASDAQ:TNXP)
www.4-traders.com - December 27 at 8:43 AM
News IconCan This Stock Grab Upward Traction: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Prospect Journal (NASDAQ:TNXP)
prospectjournal.com - December 21 at 2:07 AM
News IconTonix Pharmaceuticals lands breakthrough status for PTSD drug (NASDAQ:TNXP)
www.bioworld.com - December 20 at 9:05 PM
News Icon84. Tonix Pharmaceuticals (TNXP) Stock: Stock Rips Higher On Breakthrough Therapy Designation (NASDAQ:TNXP)
cnafinance.com - December 20 at 9:05 PM
4-traders.com logoTONIX PHARMACEUTICALS HOLDING CORP. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:TNXP)
www.4-traders.com - December 20 at 9:05 PM
streetinsider.com logoTonix Pharmaceuticals (TNXP) Granted FDA Breakthrough Therapy Designation for TNX-102 SL (NASDAQ:TNXP)
www.streetinsider.com - December 19 at 9:04 AM
us.rd.yahoo.com logoTonix Pharmaceuticals’ PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation by the FDA (NASDAQ:TNXP)
us.rd.yahoo.com - December 19 at 9:04 AM
us.rd.yahoo.com logo7:05 am Tonix Pharma announces that the FDA has granted Breakthrough Therapy designation to TNX-102 SL for the treatment of posttraumatic stress disorder (:PTSD) (NASDAQ:TNXP)
us.rd.yahoo.com - December 19 at 9:04 AM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Daily ... - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - December 15 at 6:46 AM
finance.yahoo.com logoTNXP: A Closer Look at the Use of MDMA for the Treatment of PTSD… (NASDAQ:TNXP)
finance.yahoo.com - December 15 at 6:46 AM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) reported Sales of 0 - The Newburgh Press (NASDAQ:TNXP)
newburghpress.com - December 10 at 7:23 PM
investingnews.com logoTonix Pharmaceuticals Presented New Clinical Results from Sub-Group Analysis of Phase 2 AtEase Study (NASDAQ:TNXP)
investingnews.com - December 10 at 1:11 AM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Bearish Target At $2 - Stock Observer (NASDAQ:TNXP)
www.thestockobserver.com - December 9 at 8:11 PM
streetinsider.com logoTonix Pharma (TNXP) Announces New Data from TNX-102 SL Phase 2 in PTSD - StreetInsider.com (NASDAQ:TNXP)
www.streetinsider.com - December 9 at 12:58 AM
finance.yahoo.com logoTonix Pharmaceuticals Presented New Clinical Results from Sub-Group Analysis of Phase 2 AtEase Study in Military-Related Posttraumatic Stress Disorder (PTSD) (NASDAQ:TNXP)
finance.yahoo.com - December 9 at 12:58 AM
finance.yahoo.com logo7:04 am Tonix Pharma announces they presented new clinical results from sub-group analysis of phase 2 AtEase Study in Military-related posttraumatic stress disorder (NASDAQ:TNXP)
finance.yahoo.com - December 9 at 12:58 AM
biz.yahoo.com logoTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements (NASDAQ:TNXP)
biz.yahoo.com - December 9 at 12:58 AM

Social

What is Tonix Pharmaceuticals Holding Corp.'s stock symbol?

Tonix Pharmaceuticals Holding Corp. trades on the NASDAQ under the ticker symbol "TNXP."

Where is Tonix Pharmaceuticals Holding Corp.'s stock going? Where will Tonix Pharmaceuticals Holding Corp.'s stock price be in 2017?

3 equities research analysts have issued 12 month target prices for Tonix Pharmaceuticals Holding Corp.'s stock. Their predictions range from $5.00 to $13.00. On average, they anticipate Tonix Pharmaceuticals Holding Corp.'s share price to reach $8.67 in the next twelve months.

When will Tonix Pharmaceuticals Holding Corp. announce their earnings?

Tonix Pharmaceuticals Holding Corp. is scheduled to release their next quarterly earnings announcement on Thursday, March, 2nd 2017.

Who owns Tonix Pharmaceuticals Holding Corp. stock?

Tonix Pharmaceuticals Holding Corp.'s stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.98%) and Kingdon Capital Management L.L.C. (1.78%). Company insiders that own Tonix Pharmaceuticals Holding Corp. stock include Bradley Saenger, Bruce Daugherty, Charles E Iv Mather, Ernest Mario, Gregory M Sullivan, John B Rhodes, Leland Gershell and Seth Lederman.

Who sold Tonix Pharmaceuticals Holding Corp. stock? Who is selling Tonix Pharmaceuticals Holding Corp. stock?

Tonix Pharmaceuticals Holding Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Kingdon Capital Management L.L.C..

Who bought Tonix Pharmaceuticals Holding Corp. stock? Who is buying Tonix Pharmaceuticals Holding Corp. stock?

Tonix Pharmaceuticals Holding Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Tonix Pharmaceuticals Holding Corp. stock in the last two years include Bradley Saenger, Bruce Daugherty, Charles E Iv Mather, Ernest Mario, Gregory M Sullivan, John B Rhodes, Leland Gershell and Seth Lederman.

How do I buy Tonix Pharmaceuticals Holding Corp. stock?

Shares of Tonix Pharmaceuticals Holding Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Tonix Pharmaceuticals Holding Corp. stock cost?

One share of Tonix Pharmaceuticals Holding Corp. stock can currently be purchased for approximately $0.55.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Earnings History Chart

Earnings by Quarter for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Dividend History Chart

Dividend Payments by Quarter for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Last Updated on 2/21/2017 by MarketBeat.com Staff